AMOÉBA
AMOEBA : A year of field trials that confirms AXPERA's strategic positioning
23 Nov 2023 17:45 CET
Subscribe
Issuer
AMOEBA
See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo
Appendix
Source
AMOEBA
Provider
Les Echos
Company Name
AMOEBA
ISIN
FR0011051598
Symbol
ALMIB
Market
Euronext Growth
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Amoéba SA published this content on 23 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 November 2023 16:57:06 UTC.
